Luxturna's EU Approval Highlights Gene Therapy Pricing Challenges

 
• By Francesca Bruce
  
DNA
Novartis's gene therapy Luxturna has been approved in the EU • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews